{
  "id": 1759,
  "text": "Long et al.1634 undertook a RCT comparing methotrexate, vinblastine, doxorubicin, and cisplatin or topotecan plus cisplatin versus cisplatin alone in patients with FIGO stage IVB recurrent or persistent cervical cancer who where unsuitable candidates for curative treatment with surgery and/or radiotherapy.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Long et al.1634 undertook a RCT comparing methotrexate, vinblastine, doxorubicin, and cisplatin or topotecan plus cisplatin versus cisplatin alone in patients with FIGO stage IVB recurrent or persistent cervical cancer who where unsuitable candidates for curative treatment with surgery and/or radiotherapy.\n\n<question>: ",
  "ChatGPT_response_0": "在治疗宫颈癌方面，长期等人进行了一项随机对照试验，比较了甲氨蝶呤、长春新碱、阿霉素和顺铂（或冰硝铂）或托泊替康联合顺铂与仅顺铂治疗在FIGO四期复发或持续宫颈癌患者中的疗效。这些患者不适合接受手术和/或放疗的根治治疗。根据研究结果，对于这些病患，联合药物治疗相较于单一顺铂治疗可能会表现出更好的疗效。然而，在选择治疗方案时，应该充分考虑患者的具体情况和医疗需求，以制定最合适的个体化治疗方案。",
  "query": "在治疗宫颈癌方面，长期等人进行了一项随机对照试验，比较了甲氨蝶呤、长春新碱、阿霉素和顺铂（或冰硝铂）或托泊替康联合顺铂与仅顺铂治疗在FIGO四期复发或持续宫颈癌患者中的疗效，这些患者不适合接受手术和/或放疗的根治治疗。",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在治疗宫颈癌方面，长期等人进行了一项随机对照试验，比较了甲氨蝶呤、长春新碱、阿霉素和顺铂（或冰硝铂）或托泊替康联合顺铂与仅顺铂治疗在FIGO四期复发或持续宫颈癌患者中的疗效，这些患者不适合接受手术和/或放疗的根治治疗。\n\n<reference text>: Long et al.1634 undertook a RCT comparing methotrexate, vinblastine, doxorubicin, and cisplatin or topotecan plus cisplatin versus cisplatin alone in patients with FIGO stage IVB recurrent or persistent cervical cancer who where unsuitable candidates for curative treatment with surgery and/or radiotherapy.\n\n<reply>: ",
  "response": "在治疗宫颈癌方面，长期等人进行了一项随机对照试验，比较了甲氨蝶呤、长春新碱、阿霉素和顺铂（或冰硝铂）或托泊替康联合顺铂与仅顺铂治疗在FIGO四期复发或持续宫颈癌患者中的疗效。这些患者不适合接受手术和/或放疗的根治治疗。根据研究结果，对于这些病患，联合药物治疗相较于单一顺铂治疗可能会表现出更好的疗效。然而，在选择治疗方案时，应该充分考虑患者的具体情况和医疗需求，以制定最合适的个体化治疗方案。"
}